TY - JOUR
AU - A. M. Stroud
AU - S. H. Curtis
AU - I. B. Weir
AU - J. J. Stout
AU - B. A. Barry
AU - W. V. Bobo
AU - A. P. Athreya
AU - R. R. Sharp
A1 - 
AB - BACKGROUND: As artificial intelligence (AI) tools are integrated more widely in psychiatric medicine, it is important to consider the impact these tools will have on clinical practice. OBJECTIVE: This study aimed to characterize physician perspectives on the potential impact AI tools will have in psychiatric medicine. METHODS: We interviewed 42 physicians (21 psychiatrists and 21 family medicine practitioners). These interviews used detailed clinical case scenarios involving the use of AI technologies in the evaluation, diagnosis, and treatment of psychiatric conditions. Interviews were transcribed and subsequently analyzed using qualitative analysis methods. RESULTS: Physicians highlighted multiple potential benefits of AI tools, including potential support for optimizing pharmaceutical efficacy, reducing administrative burden, aiding shared decision-making, and increasing access to health services, and were optimistic about the long-term impact of these technologies. This optimism was tempered by concerns about potential near-term risks to both patients and themselves including misguiding clinical judgment, increasing clinical burden, introducing patient harms, and creating legal liability. CONCLUSIONS: Our results highlight the importance of considering specialist perspectives when deploying AI tools in psychiatric medicine.
AD - Biomedical Ethics Program, Mayo Clinic, Rochester, MN, United States.; Alix School of Medicine, Mayo Clinic, Rochester, MN, United States.; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, United States.; Department of Behavioral Sciences & Social Medicine, College of Medicine, Florida State University, Tallahassee, FL, United States.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
AN - 39928397
BT - JMIR Ment Health
C5 - Education & Workforce; HIT & Telehealth
DA - Feb 10
DO - 10.2196/64414
DP - NLM
ET - 20250210
JF - JMIR Ment Health
LA - eng
N2 - BACKGROUND: As artificial intelligence (AI) tools are integrated more widely in psychiatric medicine, it is important to consider the impact these tools will have on clinical practice. OBJECTIVE: This study aimed to characterize physician perspectives on the potential impact AI tools will have in psychiatric medicine. METHODS: We interviewed 42 physicians (21 psychiatrists and 21 family medicine practitioners). These interviews used detailed clinical case scenarios involving the use of AI technologies in the evaluation, diagnosis, and treatment of psychiatric conditions. Interviews were transcribed and subsequently analyzed using qualitative analysis methods. RESULTS: Physicians highlighted multiple potential benefits of AI tools, including potential support for optimizing pharmaceutical efficacy, reducing administrative burden, aiding shared decision-making, and increasing access to health services, and were optimistic about the long-term impact of these technologies. This optimism was tempered by concerns about potential near-term risks to both patients and themselves including misguiding clinical judgment, increasing clinical burden, introducing patient harms, and creating legal liability. CONCLUSIONS: Our results highlight the importance of considering specialist perspectives when deploying AI tools in psychiatric medicine.
PY - 2025
SN - 2368-7959
SP - e64414
ST - Physician Perspectives on the Potential Benefits and Risks of Applying Artificial Intelligence in Psychiatric Medicine: Qualitative Study
T1 - Physician Perspectives on the Potential Benefits and Risks of Applying Artificial Intelligence in Psychiatric Medicine: Qualitative Study
T2 - JMIR Ment Health
TI - Physician Perspectives on the Potential Benefits and Risks of Applying Artificial Intelligence in Psychiatric Medicine: Qualitative Study
U1 - Education & Workforce; HIT & Telehealth
U3 - 10.2196/64414
VL - 12
VO - 2368-7959
Y1 - 2025
ER -